Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-478-8 | CAS number: 1327-43-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral: Silicic acid, aluminium magnesium sodium salt
LD50: > 2000 mg/kg bw for rats (Colas 2009)
In accordance with the OECD guideline 423, the LD50 cut-off of the test item may be considered higher than 5000 mg/kg bw by oral route in the rat.
Inhalation:
Synthetic amorphous silica: The acute inhalation of dust may cause local irritation to nasal, bronchiolar and ocular mucous membranes. Synthetic amorphous silica dusts are considered as acutely non-toxic.
Dermal: various forms of synthetic amorphous silica
LD50: > 5000 mg/kg bw for rabbit after 14 observation days (Calkins 1978a-e)
LD50: > 2000 mg/kg bw for rabbit after 2 observation days (Calkins 1976)
Key value for chemical safety assessment
Additional information
Oral
Only secondary literature is available on Silicic acid, aluminium magnesium salt (MAS) for acute oral toxicity. The original study is not available and documentation of the reviewed data is limited. Therefore data of MAS are insufficient for assessment. However, there are data for the structurally related compound Silicic acid, aluminium magnesium sodium salt.
The acute oral toxicity of Silicic acid, aluminium magnesium sodium salt (SMAS) was tested according to the OECD guideline 423 (Colas 2009). The test substance was administered to female rats at a dose of 2000 mg/kg bw. During the observation period of 14 days, no signs of toxicity or mortality were recorded. In accordance with the OECD guideline 423, the LD50 cut-off of the test item may be considered higher than 5000 mg/kg bw for the oral route in the rat.
The acute oral LD50 value for Silicic acid, aluminium magnesium salt (MAS) was calculated > 50,000 mg/kg bw in mice (Munch 1944).Based on the limited documentation of the reviewed study, available data of MAS are insufficient for assessment and only the LD50 value of Silicic acid, aluminium magnesium sodium salt (SMAS) was taken into account for risk assessment.
Inhalation
No experimental data are available on Silicic acid, aluminium magnesium salt for acute inhalation toxicity, but there is an acute inhalation study performed with dry dust of the structurally related compound Cab-O-Sil M5 (Cabot 1981). However, this study was hampered by the technical problem to achieve the recommended highest test concentration of 5000 mg/m3. In the study of Cabot (1981), rats were exposed to an average concentration of 2080 mg/m3Cab-O-Sil M5 (MMAD = 0.76 µm) for 4 hours. All animals survived. Clinical symptoms were nasal discharge during exposure, crusty eyes, crusty nose and alopecia at 14 days post-exposure. No macroscopic organ lesions were observed, but one animal showed discoloration of the lung. Measuring the particle size distribution of Cab-O-Sil M5, approx. 84% of the particles had a diameter of ≤ 3 µm and approx. 98% ≤ 10 µm.
Under experimental conditions, the particle size distribution of Silicic acid, aluminium magnesium salt (MAS) showed that approx. 28% of the particles had a diameter of ≤ 2 µm and approx. 70% of ≤ 10 µm (Grace 2009). Thus the particle size distribution of MAS is in the same order of magnitude as of Cab-O-Sil M5. During normal handling and use, MAS usually forms agglomerates of high mass median aerodynamic diameter that are not respirable (see chapter 1.3). Taking into account these larger particles, most of the inhaled material will be retained in the upper airways and/or be swallowed. Therefore, it can be assumed that no acute toxic effects due to inhalation of MAS will occur.
Dermal
Only secondary literature is available on Silicic acid, aluminium magnesium salt (MAS) for acute dermal toxicity. The original study is not available and documentation of the reviewed data is limited. Therefore data of MAS are insufficient for assessment. However, there are data for structurally related compounds.
After acute dermal application of 2000 mg/kg bw of Syloid 244 as powder to the intact skin of rabbits for 24 hours under occlusive conditions, no signs of systemic or organ toxicity were recorded. Not even erythemas or edemas were observed 24 and 48 hours after exposition (Calkins 1976).
After acute dermal application of up to 5000 mg/kg bw of aqueous pastes of synthetic amorphous silica to the intact skin of rabbits for 24 hours under occlusive conditions, no signs of systemic or organ toxicity were noted. There were only slight reversible erythemas and partly edemas (Draize score 1; Calkins 1978 a-e).
The acute dermal LD50 value for Silicic acid, aluminium magnesium salt (MAS) was calculated > 3500 mg/kg for rabbits (Hazelton Laboratories, Inc. 1968). Based on the limited documentation of the reviewed study, the available data of MAS are insufficient for assessment and only data of the structurally related compounds were taken into account for risk assessment.
Justification for classification or non-classification
Oral
According to the criteria for classification, packaging and labelling of dangerous substances and preparations in accordance with the E. E. C. Directives 67/548, 2001/59 and 99/45, the test item silicic acid, aluminium magnesium salt (MAS) does not need to be classified. No symbol and risk phrase are required.
In accordance with the Globally Harmonised System (Regulation (EC) No 1272/2008), the test item does not need to be classified. No signal word and hazard statement are required.
Inhalation
Taking into account that MAS usually forms larger particles that are not respirable, no acute inhalation toxicity is expected from the exposure to MAS. No need for classification.
Dermal
Based on structure analogy, no acute dermal toxicity is expected to occur likewise from the exposure to silicic acid, aluminium magnesium salt for which corresponding studies are not available. The test item does not need to be classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.